Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dasatinib in Patients With Waldenström Macroglobulinemia (WM) Progressing on Ibrutinib

NCT04115059 is registered in ClinicalTrials.gov with Jorge J. Castillo, MD as lead sponsor.

NCT NCT04115059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04115059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dasatinib in Patients With Waldenström Macroglobulinemia (WM) Progressing on Ibrutinib
Lead sponsor
Jorge J. Castillo, MD
Phase
Phase 1
Overall status
Terminated
Start date
November 4, 2019
Completion date
December 31, 2021
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dasatinib, waldenstrom macroglobulinemia